Extracorporeal membranous oxygenation (ECMO) in neonates and children experiences of a multidisciplinary paediatric intensive care unit by IVAN VIDMAR et al.
 17www.signavitae.com
Extracorporeal membranous 
oxygenation (ECMO) in 
neonates and children 




Extracorporeal membranous oxygenation ECMO was applied in 18 patients. All children had deep hypoxia and 80% prob-
ability of dying. Average duration of ECMO in newborns was 131 hours, and in older patients 253 hours. Seven patients were 
discharged from the intensive care unit (late survivors), 5 of them are in perfect somatic and mental condition.
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Introduction
Extracorporeal membranous oxygena-
tion (ECMO) is an established treatment 
of neonates and  children with severe 
yet amenable lung or heart failure. From 
the technical point of view it follows the 
same principle as the extracorporeal 
circulation during the by-pass surgery, 
but it is adapted to the long-term use. In 
the year 1976, Bartlett (1) presented the 
first group of neonates treated by the 
ECMO. To initiate ECMO, cannulae are 
placed in large blood vessels to provide 
access to the patient’s blood. Anticoag-
ulant drugs (heparin) are given to pre-
vent blood clotting. The ECMO machine 
continuously pumps blood from the 
patient through a membrane oxygena-
tor that imitates the gas exchange proc-
ess of the lungs, i.e. it removes carbon 
dioxide and adds oxygen. Oxygenated 
blood is then returned to the patient.
There are several forms of ECMO, the 
two most common of which are veno-
arterial (VA) and veno-venous (VV). In 
both modalities, blood drained from the 
venous system is oxygenated outside 
of the body. In VA ECMO, this blood 
is returned to the arterial system and 
in VV ECMO the blood is returned to 
the venous system. In VV ECMO, no 
cardiac support is provided.
VV ECMO can provide sufficient oxy-
genation for several weeks, allowing dis-
eased lungs to heal while the potential 
additional injury of aggressive mechani-
cal ventilation is avoided. It may therefore 
be life-saving for some patients. How-
ever, due to the high technical demands, 
cost, and risk of complications (such as 
bleeding under anticoagulant medica-
tion), ECMO is usually only considered 
as a last resort therapy.
ECMO in neonatology
At the beginning ECMO was most com-
monly used in neonatal intensive care 
units, for newborns in pulmonary dis-
tress.
Indications:
Patients with the following two major 
neonatal diagnoses require the use of 
extracorporeal membrane oxygenation 
(ECMO): 
• Primary diagnoses associated with 
primary pulmonary hypertension of the 
newborn (PPHN), including idiopathic 
PPHN, meconium aspiration syndrome, 
respiratory distress syndrome, group B 
streptococcal sepsis, and asphyxia 
• Congenital diaphragmatic hernia (CDH)
Selection criteria 
• Gestational age greater than or equal 
to 34 weeks (relative criteria) 
• Birth weight greater than or equal to 
2000 g (relative criteria)
• No significant coagulopathy or uncon-
trolled bleeding 
• No major intracranial hemorrhage 
(grade 1 intracranial hemorrhage is not 
a contra-indication) 
• Mechanical ventilation for 10-14 days 
or less (relative criteria) 
• Reversible lung injury 
• No lethal malformations 
• No major untreatable cardiac mal-
formation 
• Failure of maximal medical therapy
Qualifying patient criteria for extra-
corporeal membrane oxygenation 
Qualifying criteria are applied only when 
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the infant has reached maximal ventila-
tory support of fraction of inspired oxy-
gen [FiO2] equals 1, with peak inspira-
tory pressures (PIP) often as high as 35 
cm H2O. 
• Alveolar-arterial (A-a) gradient of 600-
624 mm Hg for 4-12 hours at sea level, 
which may be computed as follows 
(where 47=partial pressure of water 
vapor): 
(A-a)(Diffusing capacity [D] of O2 equals 
atmospheric pressure - 47 - (PaCO2 + 
PaO2])/FiO2 
• Oxygenation index (OI) greater than 
40 in 3 of 5 postductal gas determina-
tions obtained 30-60 minutes apart, 
which may be computed as follows 
(where MAP is mean airway pressure): 
OI = (MAP x FiO2 x 100)/ PaO2 
• PaO2 = 35-50 mm Hg for 2-12 hours 
• Acute deterioration 
- PaO2 less than or equal to 30-40 
mm Hg for 2 hours 
- pH less than or equal to 7.25 for 2 
hours 
- Intractable hypotension 
ECMO in paediatric 
patients 
Indications 
• Low cardiac output resulting from 
right, left, and biventricular failure fol-
lowing repair of congenital heart defect 
(this indication is frequent in neonates 
as well)
• Pulmonary vasoreactive crisis follow-
ing repair of congenital heart defect 
leading to severe hypoxemia, low car-
diac output, or both 
• As a bridge to cardiac surgery in pati-
ents with serious end-organ damage 
resulting from profound low cardiac out-
put related to congenital heart disease 
• As a bridge to cardiac transplant 
• As a bridge to recovery in temporary 
cardiomyopathy secondary to renal 
failure, myocarditis, and burns
Unlike the situation in neonates, when 
ECMO is considered in a paediatric 
patient, no clear set of inclusion or 
exclusion criteria exists. Evaluation of 
a pediatric patient for ECMO support is 
largely based on an assessment of the 
patient’s condition and the institutional 
experience with pediatric ECMO.
Management
Pulmonary system 
ECMO is used temporarily while await-
ing pulmonary recovery. In the clas-
sic use of neonatal ECMO, the typical 
ventilator settings are FiO2 of 0.30, PIP 
of 15-25 cm H2O, a positive end-expira-
tory pressure (PEEP) of 3-5 cm H2O, 
and intermittent mechanical ventila-
tion (IMV) of 10-20 breaths per minute. 
Sometimes, a high PEEP of 12-14 cm 
H20 has been used to avoid atelecta-
sis; this has been found to shorten 
the bypass time in infants. Pulmonary 
hygiene is strict and requires frequent 
endotracheal suctioning, usually every 
4 hours depending on secretions, and 
a daily chest radiograph. 
Cardiovascular system 
Systemic perfusion and intravascular 
volume should be maintained. Volume 
status can be assessed clinically by 
urine output and physical signs of per-
fusion and by measuring the central 
venous pressure and the mean arterial 
blood pressure. Native cardiac output 
can be enhanced with inotropic agents. 
An echocardiogram should be per-
formed to exclude any major congenital 
heart anomaly that may require immedi-
ate intervention other than ECMO (i.e., 
obstructed total anomalous pulmonary 
venous connection). 
Central nervous system 
Central nervous system complications 
are the most serious and are prima-
rily related to the degree of hypoxia 
and acidosis. Avoiding paralytic agents 
and performing regular neurologic 
examinations are recommended. If 
feasible, a head ultrasound should be 
obtained before beginning ECMO in a 
neonate. Reevaluation with serial head 
ultrasounds may be needed on a daily 
basis, especially after any major event. 
In patients with seizures or suspected 
seizures, aggressive treatment is rec-
ommended (i.e., phenobarbital). 
Renal system 
During the first 24-48 hours on ECMO, 
oliguria and acute tubular necrosis 
associated with capillary leak and intra-
vascular volume depletion are com-
mon because ECMO triggers an acute 
inflammatorylike reaction. The diuretic 
phase, which usually begins within 48 
hours, often is one of the earliest signs 
of recovery. If oliguria persists for 48-72 
hours, diuretics are often required to 
reduce edema. When renal failure does 
not improve, hemofiltration or hemodial-
ysis filters may be added to the circuit. 
Haematologic considerations 
To optimize oxygen delivery, the 
patient’s hemoglobin should be main-
tained at 120-150 using packed red 
blood cells (pRBCs). As a result of plate-
let consumption during ECMO, platelet 
transfusions are required to maintain 
platelet counts above 100. ACT should 
be maintained at 180-240 seconds to 
avoid bleeding complications. 
Infection control 
Strict aseptic precautions are required. 
The presence of infection is monitored 
by obtaining cultures from the circuit 
at least once per day. Based on insti-
tutional experience, the protocol fre-
quency may vary. Other appropriate 
cultures (eg, fungal and viral) should be 
sent as needed. 
Fluids, electrolytes, and nutrition 
Patients on ECMO require close moni-
toring of fluids and electrolytes. The 
high-energy requirements should be 
met using hyperalimentation tech-
niques. The patient’s weight increases 
in the first 1-3 days on ECMO because 
of fluid retention. 
Medications 
• Doses of most inotropic medications, 
such as dopamine, dobutamine, and 
epinephrine, usually can be decreased 
once the patient is on ECMO. 
• Diuretics, such as furosemide, may be 
required for mobilization of tissue fluids. 
• H2 antagonists are usually adminis-
tered for a prevention of a gastrointesti-
nal tract bleeding. 
• Only minimal sedation with fentanyl, 
midazolam, or morphine is required 
after stabilization. 
• Phenobarbital can be used if the 
patient has seizures. 
 19www.signavitae.com




• Clots in the circuit are the most com-
mon mechanical complication. Major 
clots can cause oxygenator failure, 
consumption coagulopathy, and pul-
monary or systemic emboli. 
• Cannula placement can cause dam-
age to the internal jugular vein, which 
causes massive mediastinal bleeding. 
Dissection of the carotid arterial intima 
can lead to lethal aortic dissection. It 
never happened in our patients.
• Air in the circuit can range from a few 
bubbles to a complete venous air lock. 
This air can originate in the dislodge-
ment of the venous cannula, a small 
tear in the membrane, or high partial 
pressure of oxygen in the blood. A large 
bolus of air can be fatal. 
• Oxygenator failure is defined either 
as decreased oxygen or carbon dioxide 
transfer or as presence of consump-
tive coagulopathy. A failing membrane 
should be replaced immediately. 
• Cracks in the connectors and tube 
rupture have become less serious 
problems.
• Pump malfunction may be a mani-
festation of inadequate venous return 
to the pump. 
• Heat exchanger malfunction can 
cause severe hypothermia. 
• Failure of the entire circuit, including 
the oxygen source and oxygen blend-
ers, may occur. 
• Failure of circuit-monitoring equip-
ment may occur.
Management of circuit failure 
Immediately clamp the venous line, 
open the bridge, and clamp the arte-
rial line to remove the patient from the 
ECMO. Since the patient is ventilator 
dependent, immediately bag the patient 
with FiO2=1 or shift the patient back to 
pre-ECMO ventilator settings. 
Complications in patients
Neurologic complications 
• Seizures may occur. 
• Intracranial bleeds and infarction may 
be due to ligation of the carotid artery and 
internal jugular vein, systemic heparini-
zation, thrombocytopenia, coagulopa-
thies, or systolic hypertension.
Haemorrhagic complications 
• Hemolysis and consumption coagu-
lopathy may occur. 
• Haemorrhage at the surgical site, 
cannula site, or into the site of a previ-
ous invasive procedure is a frequent 
complication because of systemic 
heparinization. 
• Intrathoracic, abdominal, or retroperi-
toneal hemorrhage may occur. 
• Decreases in platelet count occur 
because of decreased production, 
increased consumption, sequestration, 
or dilution.
Cardiac complications 
• Myocardial stun is defined as a 
decrease in the left ventricular short-
ening fraction by more than 25% with 
initiation of ECMO that returns to normal 
after 48 hours of ECMO. 
• Hypertension is a dangerous com-
plication because of the risk of haem-
orrhage and stroke. Arrhythmia may 
occur as a result of hypoxia and elec-
trolyte imbalance. 
• Symptomatic patent ductus arterio-
sus may occur. 
• Pericardial tamponade may occur.
Pulmonary complications 
• Pneumothorax is a potential compli-
cation. 
• Pulmonary haemorrhage may occur.
Renal complications 
• Oliguria is commonly observed dur-
ing the early part of ECMO. 
• Acute tubular necrosis is observed in 
some patients and may require haemo-
filtration and/or dialysis.
Gastrointestinal tract complications 
• Haemorrhage may occur as a result 
of stress, ischaemia, or bleeding ten-
dencies. 
• Direct hyperbilirubinemia and biliary 
calculi occur secondary to prolonged 
fasting and total parenteral nutrition 
(TPN), haemolysis, and diuretics.
Complications resulting from infec-
tion and sepsis 
The ECMO circuit represents a large 
intravascular foreign body; frequent 
manipulation increases the risk of sep-
sis. 
Metabolic complications 
• Acidosis or alkalosis 
• Hyperkalaemia or hypokalaemia 
• Hypernatraemia or hyponatraemia 
• Hypercalcaemia or hypocalcaemia 
• Hyperglycaemia or hypoglycaemia
Drug serum concentrations 
• ECMO may alter serum concentration 
of drugs due to increased volume of 
distribution. 
• Caution is warranted when narrow 
therapeutic drugs are administered. 
Dose alterations may be necessary. 
Weaning or trial period without extra-
corporeal membrane oxygenation 
In patients with a principal pre-ECMO 
diagnosis of respiratory failure, a trial 
period without ECMO is scheduled if (1) 
the patient demonstrates adequate gas 
exchange and is on reasonable ventila-
tory settings, and (2) the patient toler-
ates a pump flow of 10-20 ml/kg/min 
with the minimum of 200 ml/min.
Morbidity 
Medical morbidity 
• Difficulty in establishing full oral feed-
ing is common after ECMO decannula-
tion. Feeding difficulty is reported in as 
many as one third of babies, even in the 
presence of normal suck and swallow 
reflexes. 
• Somatic growth is normal in infants 
who survive following ECMO. Poor 
growth should be evaluated for another 
underlying cause. 
• Approximately 15% of infants still require 
oxygen at 28 days after ECMO. These 
children have a higher rate of rehospi-
talization for pulmonary indications, par-
ticularly in the first 6 months after ECMO. 
These children have a slightly higher 
prevalence of bronchial asthma. 
• Infants who survive following ECMO 
have a higher rate of rehospitalization for 
nonpulmonary and surgical conditions. 
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• The rate of sensorineural disabilities 
in infants who survive following ECMO 
averages 6% (range, 2-18%); devel-
opmental delay occurs in 9% (range, 
0-21%). 
• Abnormal brainstem auditory-evoked 
response (BAER) with mild-to-moder-
ate threshold elevation is seen in 25% of 
children following ECMO at discharge. 
This condition usually resolves. Sen-
sorineural hearing loss is documented 
after age 1 year in 9% (range, 4-21%) of 
children following ECMO. 
• Routine ophthalmic examinations 
during ECMO are not recommend-
ed because studies in term babies 
have not shown any occurrence of 
retinopathy. In the rare neonate with 
birth weight less than 2 kg in whom 
ECMO is used, ophthalmic examina-
tion is required prior to discharge. 
Some degree of cortical visual impair-
ment has been seen after posterior 










4 CDH1 3 75 2 1 25
4 MAS2 2 50 - 2 50
2 PPH3 2 100 1 1 50
1 HMD4 1 100 - 1 100
1 Septic shock 0 0 - 0 0
Summary
12 8 66.6 3 5 41.6
1CDH, Congenital Diaphragmatic Hernia; 2MAS, Meconium Aspiration Syndrome; 3PPH, Primary Pulmonary 
Hypertension; 4HMB, Hyaline Membrane Disease.










0 0 - 0 0
2 Dilatatory Cardio-
myopathie
1 50 1 1 50
1 Viral (RSV1) 
Pneumonia
0 0 - 0 0
1 Stun Heart2 1 100 - 1 100
1 Burns 1 100 - 1 100
Summary
6 3 50 1 2 33
1RSV, Respiratory Sintitial Virus; 2Following the Open Heart Surgery.
Table 2. Older children according to the prinicple diagnosis, immediate survival and later survival after ECMO.
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visual function has been shown to 
improve. 
• Both clinical and electroencephalo-
graphic seizure activity is reported in 
20-70% of neonates while on ECMO. 
Epilepsy is reported in 2% of patients 
at age 5 years. 
• Rare neuromotor deficits range from 
mild hypotonia to gross motor delay 
and spastic quadriparesis. 
• Psychosocial morbidity 
Increased frequency of social prob-
lems, academic difficulties at school 
age, and higher rates of attention deficit 
disorder are reported in children who 
received ECMO. The ECMO procedure 
is dramatic and highly invasive. Fami-
lies can feel isolated if no other patients 
are on ECMO in the same institution. 
At age 1 year, the stress level of the 
mother of an infant previously on ECMO 
is the same as the stress level in the 
family of a preterm infant. By age 5 
years, the family stress level is the same 
as that of the family of a healthy child in 
whom ECMO was not used. 
Type of Clinical Complication No. of Survivors No. of  Non-  survivors
Cerebral Paroxysms 2 -
Long Lasting Cerebral Convulsions 1 1
Jitterness (Tremor) 1 -
Brain Death - 1
Nosocomial Sepsis (Positive Blood Culture) 1 2
Acute Renal Syndrome 3 3
Intracranial Bleeding 1 1
Bleeding at the Site of Cannulas 2 2
Cardiac Arrest and Resuscitation 1 4
Arrhythmias - 2
Pneumothorax with Drainage 2 1
Pneumomediastinum 1 2
Pneumopericardium - 1
Type of the Mechanical Adverse Event Number
Regular Replacement of the Oxygenator 2
Rupture of the Oxygenator Membrane 3
Tubing Rupture in the Raceway of the Pump 4
Weakening of the ECMO Circuit Tube Clamp 1
Rupture of the Baloon in the Servoregulator 1
Air Entry in the ECMO Circuit 3
Table 3. Mechanical Complications Related to ECMO Support in 18 Patients.
LJubljana´s results
1994-2005
The first patient was treated by ECMO 
in our multidisciplinary paediatric inten-
sive care unit in the year 1994. In the 
period of 1994-2005, i.e. in 12 years, 
there were 18 patients who underwent 
this procedure; 12 (66%) newborns, 6 
(35%) children ranging in age from 2 
months to 2 years, and 6 children older 
than 2 years (table 1,2). The immediate 
survival means that the death occurred 
in the first 24 hours after the decannula-
tion and the late survival means that it 
occurred after 24 hours.
The most important mechanical com-
plications are summarized in table 3, 
and complications in patients are pre-
sented in table 4. The immediate sur-
vival of 18 patients was higher in the 
group of neonates (66%) compared to 
33% in the group of older patients. In 
summary, there were 11 patients who 
survived the decannulation; of these 
eleven patients, four patients died with-
in 24 hours after the decannulation. 
Five of seven late survivors have normal 
mental and somatic status. One child 
has mild motor and cognitive distur-
bances, but he is attending elementary 
school without any problems. One child 
is severely handicapped.
Table 4. The most Important Clinical Complications in 18 Patients During ECMO.
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